🇺🇸 VTRS — Viatris Inc.

Salud Compra
← Volver

Precio actual

19,91 USD

Máx. histórico

76,06

4214 días

Split 3:2 del 09/10/2003

Caída desde máximo

-73,82%

Rango 52 semanas

9,92 – 19,96

Variación hoy

+4,96%

Cierre anterior

18,97

Rango de hoy

18,80 – 19,94

Volumen hoy

14.437.429

Peor caída histórica

-88,75%

24/04/2015 → 10/04/2025

Aún sin recuperar

Volatilidad anualizada ⓘ

44,79%

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER ⓘ
—
Dividend yield
2,53% (puede no estar actualizado)
Precio objetivo analistas
20,00 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 14 horas
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,41%
Fecha de pago Importe por participación
21/08/2026 0,1200 USD
22/05/2026 0,1200 USD
09/03/2026 0,1200 USD
24/11/2025 0,1200 USD
22/08/2025 0,1200 USD
23/05/2025 0,1200 USD
10/03/2025 0,1200 USD
22/11/2024 0,1200 USD
23/08/2024 0,1200 USD
23/05/2024 0,1200 USD
08/03/2024 0,1200 USD
22/11/2023 0,1200 USD
23/08/2023 0,1200 USD
23/05/2023 0,1200 USD
08/03/2023 0,1200 USD
Splits Registrados en el histórico de precios
Fecha Ratio
09/10/2003 3:2
28/01/2003 3:2
16/08/1995 3:2
03/08/1992 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/01/2017 36,00 36,64 35,98 36,48 +1,87% 1,83% 5.124.900
24/01/2017 36,03 36,13 35,16 35,81 -0,61% 2,69% 5.067.200
23/01/2017 36,87 37,19 35,82 36,03 -2,81% 3,72% 4.735.300
20/01/2017 36,93 37,35 36,80 37,07 +0,32% 1,49% 3.587.000
19/01/2017 37,11 37,30 36,71 36,95 -0,65% 1,59% 4.062.700
18/01/2017 37,18 37,38 36,71 37,19 +0,32% 1,80% 4.247.600
17/01/2017 36,86 37,36 36,45 37,07 +0,93% 2,47% 4.542.900
13/01/2017 36,79 37,02 36,35 36,73 -0,11% 1,82% 5.031.400
12/01/2017 37,44 37,44 36,17 36,77 -1,37% 3,39% 7.167.200
11/01/2017 39,55 39,58 37,08 37,28 -4,29% 6,32% 11.809.800
10/01/2017 39,23 39,37 38,67 38,95 +0,00% 1,78% 3.409.800
09/01/2017 38,50 39,13 38,41 38,95 +1,17% 1,87% 3.382.200
06/01/2017 38,87 39,08 37,95 38,50 -1,69% 2,91% 5.723.600
05/01/2017 38,95 39,47 38,77 39,16 -1,19% 1,80% 5.799.300
04/01/2017 39,32 40,08 39,25 39,63 +1,33% 2,11% 6.581.800
03/01/2017 38,48 39,28 38,42 39,11 +2,52% 2,23% 5.031.900
30/12/2016 37,98 38,79 37,84 38,15 +2,06% 2,50% 6.312.700
29/12/2016 37,47 38,00 37,18 37,38 +0,46% 2,19% 3.553.000
28/12/2016 37,69 37,79 36,90 37,21 -0,98% 2,36% 5.533.600
27/12/2016 37,48 38,24 37,46 37,58 +0,21% 2,08% 3.860.100
23/12/2016 37,26 37,55 37,20 37,50 +0,51% 0,94% 2.077.700
22/12/2016 37,39 37,81 37,13 37,31 -0,56% 1,82% 3.122.900
21/12/2016 37,40 37,89 37,05 37,52 +0,62% 2,25% 4.093.000
20/12/2016 37,56 37,83 37,14 37,29 -0,53% 1,84% 2.479.900
19/12/2016 37,63 38,29 37,38 37,49 -0,87% 2,42% 2.727.900
16/12/2016 38,09 38,23 37,63 37,82 +0,16% 1,58% 6.542.300
15/12/2016 37,64 38,10 37,32 37,76 +0,19% 2,07% 4.591.700
14/12/2016 38,15 38,17 37,13 37,69 -1,59% 2,73% 5.845.700
13/12/2016 37,70 38,45 37,64 38,30 +3,15% 2,15% 7.035.600
12/12/2016 36,69 37,30 36,35 37,13 +1,70% 2,59% 4.876.600